Search results for "mutation."

showing 10 items of 2808 documents

Allelic age of the USH2A c.2299delG mutation

2010

24 p., figuras y bibliografía

Gene isoformUsher syndromePopulationc.2299delGSingle-nucleotide polymorphismBiologyPolymorphism Single NucleotideArticleLinkage DisequilibriumWhite PeopleExonUSH2Aotorhinolaryngologic diseasesGeneticsmedicineHaplotypeHumansAlleleeducationGeneAllelesPhylogenyGenetics (clinical)GeneticsExtracellular Matrix Proteinseducation.field_of_studyHaplotypemedicine.diseaseHaplotypesMutationDatingUsher Syndromes
researchProduct

BRAF mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer

2010

Hypoxia-inducible factor-1α is found frequently overexpressed in solid tumors cells, exerting an important role in angiogenesis, glucose metabolism, cell proliferation, survival and invasion. In thyroid carcinomas, hypoxia-inducible factor-1α expression was found increased in differentiated, poorly differentiated, medullary and anaplastic variants. Hypoxia represents the principal stimulus responsible for hypoxia-inducible factor-1α induction. Other nonhypoxic stimuli increase hypoxia-inducible factor-1α synthesis through the activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in a cell-type-specific manner. We have previously shown the role of BRAFV600…

Gene knockdownPathologymedicine.medical_specialtyMutationCell growthAngiogenesisBiologymedicine.diseasemedicine.disease_causePathology and Forensic MedicinePapillary thyroid cancerThyroid carcinomaCancer researchmedicineSignal transductionPAX8Modern Pathology
researchProduct

Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology

2020

Inter-patient molecular heterogeneity is the major declared driver of an expanding variety of anticancer drugs and personalizing their prescriptions. Here, we compared interpatient molecular heterogeneities of tumors and repertoires of drugs or their molecular targets currently in use in clinical oncology. We estimated molecular heterogeneity using genomic (whole exome sequencing) and transcriptomic (RNA sequencing) data for 4890 tumors taken from The Cancer Genome Atlas database. For thirteen major cancer types, we compared heterogeneities at the levels of mutations and gene expression with the repertoires of targeted therapeutics and their molecular targets accepted by the current guideli…

Gene mutationMedical OncologychemotherapyGenomeTranscriptomelcsh:ChemistryDrug Delivery SystemsProstateNeoplasmstumor heterogeneityMedicineCluster AnalysisMolecular Targeted TherapyPathology MolecularPrecision Medicinelcsh:QH301-705.5targeted therapeuticscancer drugsSpectroscopyExome sequencingGeneral MedicineGenomicspersonalized medicineComputer Science ApplicationsDrug repositioningmedicine.anatomical_structureAntineoplastic AgentsComputational biologyCatalysisArticleInorganic Chemistrymolecular diagnosticsGenetic HeterogeneityDrug TherapyExome SequencingHumansPhysical and Theoretical ChemistryMolecular Biologygenomeclinical oncologybusiness.industryOrganic ChemistryMolecular diagnosticsmutationslcsh:Biology (General)lcsh:QD1-999MutationPersonalized medicinebusinesstranscriptomeInternational Journal of Molecular Sciences
researchProduct

How Fragile We Are: Influence of Stimulator of Interferon Genes (STING) Variants on Pathogen Recognition and Immune Response Efficiency.

2022

AbstractThe STimulator of INterferon Genes (STING) protein is a cornerstone of the human immune response. Its activation by cGAMP upon the presence of cytosolic DNA stimulates the production of type I interferons and inflammatory cytokines which are crucial for protecting cells from infections. STING signaling pathway can also influence both tumor-suppressive and tumor-promoting mechanisms, rendering it an appealing target for drug design. In the human population, several STING variants exist and exhibit dramatic differences in their activity, impacting the efficiency of the host defense against infections. Understanding the differential molecular mechanisms exhibited by these variants is o…

General Chemical EngineeringPopulationLibrary and Information SciencesBiologyProinflammatory cytokinemutation.Immune system[CHIM]Chemical SciencesHumanseducationPathogenwild-typeeducation.field_of_studyWild typeMembrane ProteinsGeneral ChemistrySTING proteinImmunity InnateComputer Science ApplicationsStingmolecular dynamics simulationSettore CHIM/03 - Chimica Generale E InorganicaStimulator of interferon genesImmunologyInterferonsSignal transductionJournal of chemical information and modeling
researchProduct

Exploring Multiobjective Optimization for Multiview Clustering

2018

We present a new multiview clustering approach based on multiobjective optimization. In contrast to existing clustering algorithms based on multiobjective optimization, it is generally applicable to data represented by two or more views and does not require specifying the number of clusters a priori . The approach builds upon the search capability of a multiobjective simulated annealing based technique, AMOSA, as the underlying optimization technique. In the first version of the proposed approach, an internal cluster validity index is used to assess the quality of different partitionings obtained using different views. A new way of checking the compatibility of these different partitioning…

General Computer ScienceComputer science02 engineering and technologycomputer.software_genreMulti-objective optimizationCluster validity index020204 information systemsSimulated annealingNew mutation0202 electrical engineering electronic engineering information engineeringA priori and a posteriori020201 artificial intelligence & image processingData miningCluster analysisMultiple viewcomputerACM Transactions on Knowledge Discovery from Data
researchProduct

EGFR genomic alterations in cancer: prognostic and predictive values.

2011

The role of EGFR in cancer development and progression has been recognized for long time in a variety of human malignancies including lung, head and neck, colon, breast, ovary and glioma. Recently its role as a target of antineoplastic agents has also been identified and a variety of EGFR-targeted drugs is already being used in a clinical setting and others are at present under investigation. Many data involving EGFR protein expression are now available for the choice of anti-EGFR monoclonal antibodies in colorectal cancer and with regard to EGFR gene mutations for the choice of tyrosine kinase inhibitors in lung cancer. Other EGFR-related molecular factors, including the EGFR gene copy num…

General Immunology and MicrobiologySettore MED/06 - Oncologia MedicaColorectal cancerbusiness.industryGene DosageCancerGene mutationmedicine.diseasePrognosisGene dosageGeneral Biochemistry Genetics and Molecular BiologyErbB ReceptorsGliomaMutationmedicineCancer researchHumansCopy-number variationEGFR cancerLung cancerbusinessTyrosine kinaseFrontiers in bioscience (Elite edition)
researchProduct

Histopathology of Skeletal Muscle in a Distal Motor Neuropathy Associated with a Mutant CCT5 Subunit: Clues for Future Developments to Improve Differ…

2023

Genetic chaperonopathies are rare but, because of misdiagnosis, there are probably more cases than those that are recorded in the literature and databases. This occurs because practitioners are generally unaware of the existence and/or the symptoms and signs of chaperonopathies. It is necessary to educate the medical community about these diseases and, with research, to unveil their mechanisms. The structure and functions of various chaperones in vitro have been studied, but information on the impact of mutant chaperones in humans, in vivo, is scarce. Here, we present a succinct review of the most salient abnormalities of skeletal muscle, based on our earlier report of a patient who carried…

General Immunology and Microbiologymuscle pathologydesminmolecular dynamics simulationsmolecular chaperonehuman CCTGeneral Biochemistry Genetics and Molecular BiologyCCT5 mutationdistal neuropathieprotein aggregatechaperone systemimmunohistochemistrychaperonopathieskeletal muscleimmunofluorescenceGeneral Agricultural and Biological Sciencesapical domainBiology
researchProduct

Transcription in bacteriophage f1-infected Escherichia coli: RNA synthesized on DNA of deletion mutant PII shows the existence of a two-site terminat…

1984

Two different transcripts are synthesized on the DNA of deletion mutant PII of bacteriophage f1 in E. coli cells infected with this miniphage. Both RNA species appear to be primary transcripts and differ by about 100 nucleotides at their 3'OH end. Mapping of these molecules on the miniphage genome suggests that a two-site terminator is active at the end of the I region of transcription of bacteriophage f1.

Genes ViralTranscription GeneticBiologymedicine.disease_causeColiphagesBacteriophageNucleic acid thermodynamicschemistry.chemical_compoundTranscription (biology)GeneticsmedicineNucleotideMolecular BiologyEscherichia colichemistry.chemical_classificationBase SequenceRNAChromosome MappingNucleic Acid Hybridizationbiology.organism_classificationMolecular biologyTerminator (genetics)chemistryDNA ViralMutationNucleic Acid ConformationRNA ViralDNAMoleculargeneral genetics : MGG
researchProduct

Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.

2005

Cancer/germline (CG) antigens represent promising targets for widely applicable mono- and multiantigen cancer vaccines for nonsmall cell lung cancer (NSCLC). Since little is known about their composite expression in this tumor type, we analyzed 7 CG genes (MAGE-A3, NY-ESO-1, LAGE-1, BRDT, HOM-TES-85, TPX-1 and LDHC) in 102 human NSCLC specimens. About 81% of NSCLC express at least 1 and half of the specimen at least 2 CG genes. Activation of most of these genes occurs more frequently in squamous cell cancer than in adenocarcinomas. Even though we found all genes but one to be regulated by genomic methylation, not all of them are co-expressed. In particular, combining CG genes not localized …

Genetic MarkersCancer ResearchLung Neoplasms/geneticsLung NeoplasmsBiologyGermlineEpigenesis GeneticGermline mutationAntigens NeoplasmCarcinoma Non-Small-Cell Lung/geneticsCarcinoma Non-Small-Cell LungmedicineTumor Cells CulturedHumansGeneGerm-Line MutationGene Expression ProfilingCancerMethylationDNA Methylationmedicine.diseaseGene expression profilingOncologyDNA methylationImmunologyCancer researchCancer/testis antigensInternational journal of cancer
researchProduct

Cyclosporin A resistance of herpes simplex virus-induced "fusion from within" as a phenotypical marker of mutations in the Syn 3 locus of the glycopr…

1994

We here report research in which nine strains of Herpes simplex virus (HSV) with fusing activity were investigated in order to establish precise phenotypical markers of mutations in the carboxy terminus of glycoprotein B (gB). The gene region encoding the carboxy terminus of gB was isolated, then cloned, and finally sequenced. Our investigation showed that seven strains have different mutations in the syn 3 locus. We observed no base difference in the gB gene region encoding the carboxy terminus of gB of two other strains. Strains with a mutation in the carboxy terminus of gB induced fusion from within (FFWI) in the presence of Cyclosporin A (CyA) at a concentration up to 150 µM. There are …

Genetic MarkersGenes ViralLocus (genetics)Biologymedicine.disease_causeVirusCell LineCell FusionViral Envelope ProteinsVirologyCyclosporin aGeneticsmedicineAnimalsHumansSimplexvirusMolecular BiologyGenechemistry.chemical_classificationGeneticsCell fusionDrug Resistance MicrobialGeneral MedicinePhenotypeMolecular biologyHerpes simplex virusPhenotypechemistryMutationCyclosporineGlycoproteinViral Fusion ProteinsVirus genes
researchProduct